DOCSLIB.ORG

The Bedtime Solution Mitchell Levy, MD, and Kimberly Mclaren, MD

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Bedtime Solution Mitchell Levy, MD, and Kimberly Mclaren, MD Cases That Test Your Skills The bedtime solution Mitchell Levy, MD, and Kimberly McLaren, MD Depressed and suicidal, Ms. W had not found relief after How would you years of medication trials and electroconvulsive therapy. handle this case? Visit CurrentPsychiatry.com Then her psychiatrists tried a novel intervention. to input your answers and see how your colleagues responded CASE Refractory depression • nortriptyline for migraine headache pro- Ms. W, age 38, is brought to the emergency de- phylaxis. partment after her son fi nds her unresponsive Some medications were not tolerated, pri- ® and calls 911. Suff ering from worsening depres- Dowdenmarily because Health of increased Media anxiety. Those sion, she wrote a note telling her children good- that were tolerated were adequate trials in bye, and overdosed on zolpidemCopyright from anFor old personalterms of dose titrationuse andonly length. High-dose prescription and her daughter’s opioids. After fl uoxetine (80 mg/d) augmented by risperi- being evaluated and medically cleared in the done (0.375 to 0.5 mg/d) produced the most emergency department, Ms. W was admitted to reliable and signifi cant improvement. the psychiatric unit. Ms. W had 2 courses of electroconvulsive Ms. W has a history of recurrent major de- therapy (ECT) totaling 30 treatments—most pressive disorder that developed after she was recently in 2007—that resulted in signifi cant sexually abused by a relative as a teen. She also memory loss with limited benefi t. Premen- has bulimia nervosa, alcohol dependence, and strual worsening of depression and suicidality posttraumatic stress disorder. She was hospital- were noted. In collaboration with her gynecolo- ized twice for depression and suicidality but had gist, Ms. W was treated with a 3-month trial of not previously attempted suicide. In the mid- leuprolide to suppress her ovarian axis, which to-late 1990s, she had trials of paroxetine, clomi- was helpful. In 2008 she underwent bilateral pramine, lithium, and bupropion. oophorectomy. She has not had symptoms of She was seen regularly in our outpatient mood elevation or psychosis. Family history in- psychiatry clinic for medication management cludes schizophrenia, depression, anxiety, and and supportive psychotherapy. Since being fol- alcoholism. lowed in our clinic starting in early 2005, she has In the months before hospitalization, Ms. had the following medication trials: W had been increasingly depressed and in- • fl uoxetine, citalopram, venlafaxine XR, termittently suicidal, although she did not and duloxetine for depression endorse a specifi c plan or intention to harm • atomoxetine, buspirone, liothyronine, herself because she was concerned about risperi done, and aripiprazole for anti- the impact suicide would have on her chil- depressant augmentation dren. Weight gain with risperidone had reac- • lorazepam, clonazepam, and gabapentin for anxiety Dr. Levy is assistant professor and Dr. McLaren is acting assistant professor, department of psychiatry, University of Washington, Current Psychiatry • zolpidem and trazodone for insomnia Seattle, WA. Vol. 8, No. 12 91 For mass reproduction, content licensing and permissions contact Dowden Health Media. 091_CPSY1209 091 11/16/09 12:12:26 PM Cases That Test Your Skills tivated body image issues, so Ms. W stopped gested that rates of total sleep deprivation- taking this medication 2 weeks before hos- induced mania are likely to be similar to pitalization. Her depression became worse, or less than those reported for antidepres- and she began using her husband’s hydroco- sants. Because sleep deprivation can induce done/acetaminophen prescription. seizures, this therapy is contraindicated for patients with epilepsy or those at risk for What depression treatment would you con- seizures.4 sider next for Ms. W? a) retrial of fl uoxetine and an atypical What adjuncts could help sustain a antipsychotic with a lower potential for depressed patient’s response to partial weight gain, such as aripiprazole sleep deprivation? b) lithium with a tricyclic antidepressant a) light therapy c) bilateral ECT b) lithium Clinical Point d) chronotherapy utilizing sleep deprivation c) antidepressants Sleep deprivation d) sleep-phase advance The authors’ observations e) all of the above is a rapid, eff ective Approximately 40% of patients with ma- treatment for jor depression fail to respond to an initial Researchers have successfully explored depression but antidepressant trial.1 An additional 50% of strategies to reduce the rate of depressive up to 80% of these patients will be treatment-resistant relapse after sleep deprivation, including 1 patients experience to a subsequent antidepressant. Patients coadministering light therapy, antidepres- may be progressively less likely to respond sants, lithium (particularly for bipolar depressive relapse to additional medication trials.2 depression), and sleep-phase advance.4 One of the most rapid-acting and effec- Sleep-phase advance involves shifting the tive treatments for unipolar and bipolar de- sleep-wake schedule to a very early sleep pression is sleep deprivation. Wirz-Justice time and wake-up time (such as 5 PM to et al3 found total or partial sleep depriva- midnight) for 1 day, and then pushing back tion during the second half of the night this schedule by 1 or 2 hours each day until induced rapid depression remission. Re- the patient is returned to a “normal” sleep sponse rates range from 40% to 60% over schedule (such as 10 PM to 5 AM). Research- hours to days.4 Sleep deprivation also can ers have demonstrated that sleep-phase reduce suicidality in patients with season- advance can have antidepressant effects.7 al depression.5 This treatment has not been widely employed, however, because up to 80% of patients who undergo sleep depri- TREATMENT Sleep manipulation vation experience rapid and signifi cant de- Ms. W is continued on fl uoxetine, 80 mg/d. pressive relapse.4 We opt for a trial of partial sleep deprivation Sleep deprivation usually is well toler- and sleep-phase advance for Ms. W because ated. Potential side effects include: of the severity of her depression, her mul- • headache tiple ineff ective or poorly tolerated medica- • gastrointestinal upset tion trials, and limited benefi t from ECT. This • fatigue treatment involves instituting partial sleep • cognitive impairment. deprivation the fi rst night and subsequently Less often, patients report worsening of advancing her sleep phase over the next sev- depressive symptoms and, rarely, suicidal eral days (Table 1, page 96). ideation or psychosis.4 Mania or hypoma- Although she is sleepy the morning after nia are potential complications of sleep partial sleep deprivation, Ms. W reports a loss for patients with bipolar or unipolar marked improvement in her mood, decline Current Psychiatry 92 December 2009 depression. In a review, Oliwenstein6 sug- in hopelessness, and absence of suicidal continued on page 96 092_CPSY1209 092 11/16/09 12:12:30 PM Cases That Test Your Skills continued from page 92 Table 1 Ms. W’s chronotherapy protocol: Hours permitted for sleep* Day number 12345 Sleep deprivation 9 PM to 2 AM Sleep-phase 5 PM to 7 PM to 9 PM to 10 PM to advance midnight 2 AM 4 AM 5 AM *Treatment was implemented while Ms. W was hospitalized ideation. She continues the sleep-phase previously responded to antidepressant aug- advance protocol for the next 3 nights and mentation with an atypical antipsychotic we participates in cognitive-behavioral therapy add aripiprazole and titrate the dosage to 7.5 groups and ward activities. Psychiatric unit mg/d. We also continue fl uoxetine, 80 mg/d, staff support her continued wakefulness dur- and add trazodone, 100 mg at bedtime, and ing sleep manipulation. Because Ms. W had hydroxyzine, 25 mg as needed. MAINTAINING WELLNESS IN PATIENTS WITH BIPOLAR DISORDER moving beyond eff icacy to effectiveness FREE 2.0 CME CREDITS FREE PARTICIPATING FACULTY SUPPLEMENT TO Sponsored by 2.0 CME S. Nassir Ghaemi, MD, MPH Available at www.currentpsychiatry.com credits A DOWDEN PUBLICATION October 2009 Director, Mood Disorders and Psychopharmacology Maintaining wellness in Available at Programs patients with Professor of Psychiatry CurrentPsychiatry.com Tufts Medical Center bipolar disorder: Boston, Massachusetts MOVING BEYOND EFFICACY TO Robert M. A. Hirschfeld, MD EFFECTIVENESS Titus H. Harris Chair FACULTY Harry K. Davis Professor S. Nassir Ghaemi, MD, MPH Robert M. A. Hirschfeld, MD Professor and Chairperson Claudia F. Baldassano, MD Department of Psychiatry and Behavioral Sciences University of Texas Medical Branch Galveston, Texas This supplement was submitted by SciMed and supported by an educational grant from AstraZeneca. It was peer Claudia F. Baldassano, MD reviewed by CURRENT PSYCHIATRY. Supported by an educational grant from Assistant Professor of Psychiatry Director, Bipolar Outpatient Program Hospital of the University of Pennsylvania A CME-certifi ed supplement enduring from the 2009 CURRENT PSYCHIATRY/AACP Symposium. Philadelphia, Pennsylvania This activity is sponsored by SciMed and supported by an educational grant from AstraZeneca. It was peer reviewed by CURRENT PSYCHIATRY. 096_CPSY1209 096 11/17/09 2:45:39 PM Cases That Test Your Skills The authors’ observations Table 2 Chronotherapy incorporates manipulations Sleep deprivation for depression: of the sleep/wake cycle such as sleep depri- Possible mechanisms vation and dark or light therapy. It may use combinations of interventions to generate Mechanism Components and sustain a response in
Load more

Recommended publications
  • Association of Locomotor Activity During Sleep Deprivation Treatment with Response
    ORIGINAL RESEARCH published: 21 July 2020 doi: 10.3389/fpsyt.2020.00688 Association of Locomotor Activity During Sleep Deprivation Treatment With Response Jerome Clifford Foo 1*, Lea Sirignano 1, Nina Trautmann 1,2,3, Jinhyuk Kim 4, Stephanie H. Witt 1, Fabian Streit 1, Josef Frank 1, Lea Zillich 1, Andreas Meyer-Lindenberg 2, Ulrich Ebner-Priemer 5, Claudia Schilling 2, Michael Schredl 2, Yoshiharu Yamamoto 6, Maria Gilles 2, Michael Deuschle 2 and Marcella Rietschel 1 1 Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany, 2 Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany, 3 Department of Child and Adolescent Psychiatry Edited by: and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Andrea De Bartolomeis, Germany, 4 Department of Informatics, Graduate School of Integrated Science and Technology, Shizuoka University, University of Naples Federico II, Italy Shizuoka, Japan, 5 Department of Sport and Sport Science, Karlsruhe Institute of Technology, Karlsruhe, Germany, 6 Reviewed by: Department of Physical and Health Education, Graduate School of Education, The University of Tokyo, Tokyo, Japan Vincenzo Natale, University of Bologna, Italy Disrupted circadian rhythms and sleep patterns are frequently observed features of Mirko Manchia, University of Cagliari, Italy psychiatric disorders, and especially mood disorders. Sleep deprivation treatment (SD) *Correspondence: exerts rapid but transient antidepressant effects in depressed patients and has gained Jerome Clifford Foo recognition as a model to study quick-acting antidepressant effects. It is of interest how [email protected] locomotor activity patterns during SD might be associated with and potentially predict Specialty section: treatment response.
    [Show full text]
  • The Effect of Bright Light on Affiliation
    THE EFFECT OF ACUTE BRIGHT LIGHT EXPOSURE ON SOCIAL AFFILIATION By Copyright 2014 YEVGENY BOTANOV Submitted to the graduate degree program in Psychology and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ________________________________________ Chairperson Stephen S. Ilardi, PhD ________________________________________ Monica Biernat, PhD ________________________________________ Rick E. Ingram, PhD ________________________________________ Sarah B. Kirk, PhD ________________________________________ Kyeung Hae Lee, PhD Date Defended: July 02, 2014 ii The Dissertation Committee for Yevgeny Botanov certifies that this is the approved version of the following dissertation: THE EFFECT OF ACUTE BRIGHT LIGHT EXPOSURE ON SOCIAL AFFILIATION ________________________________________ Chairperson Stephen S. Ilardi, PhD Date Approved: July 02, 2014 iii Abstract In recent decades, bright light has emerged as a useful tool in numerous clinical and non-clinical applications, with the potential to influence circadian rhythms, sleep, mood, and several other functional domains. However, despite the existence of plausible neurological pathways through which light could also influence social behavior, little is known at this point about the direct effects of bright light exposure on social interaction. Accordingly, the present study – utilizing a sample of young adults endorsing at least mild seasonal fluctuations in clinically relevant domains – examined the acute effects
    [Show full text]
  • Seasonal Changes in Mood and Behavior Among Diverse
    SEASONAL CHANGES IN MOOD AND BEHAVIOR AMONG CHILDREN AND ADOLESCENTS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Katharine Davies Smith, M.A. ***** The Ohio State University 2005 Dissertation Committee: Dr. Mary Fristad, Advisor Approved by Dr. Steven Beck ______________________ Dr. Michael Vasey Advisor Dr. Nancy Ryan-Wenger Department of Psychology Copyright by Katharine Davies Smith 2005 ABSTRACT Seasonal mood disorder (SMD) is likely prevalent among children and adolescents; however, there are few empirical investigations of pediatric SMD in the literature. To contribute to the field, the current study investigates the seasonality of mood and behavior among children and adolescents using longitudinal data collected from 1987 to 1998. One hundred eleven youths diagnosed with depression, 369 bereaved youths, 129 community controls, and their parents completed individual assessments at baseline, five, thirteen, and twenty-five months later. Assessment materials include several measures of depressive symptoms and diagnostic instruments. Multilevel analyses were conducted using MlwiN software. According to both parent- and child-report, youths from all three groups earn significantly higher total scores on measures of depression during the winter than the summer. On the other hand, significant seasonal effects do not arise for a measure of overall psychopathology. This implies that seasonality is limited to mood disorders. While this seasonal effect is significant, actual changes of mean scores on measures of depression from the summer to the winter are minimal, suggesting that season may have little affect on the mood and behavior for the majority of participants from each group.
    [Show full text]
  • Coupling Sleep-Wake and Circadian Neurobiology to the Antidepressant Effects of Ketamine
    Pharmacology & Therapeutics 221 (2021) 107741 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine S. Kohtala a,b,1, O. Alitalo a,b,1,M.Rosenholma,b, S. Rozov a,b,T.Rantamäkia,b,⁎ a Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland b SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland article info abstract Available online 12 November 2020 Several studies have demonstrated the effectiveness of ketamine in rapidly alleviating depression and suicidal ideation. Intense research efforts have been undertaken to expose the precise mechanism underlying the antide- Keywords: pressant action of ketamine; however, the translation of findings into new clinical treatments has been slow. This Sleep translational gap is partially explained by a lack of understanding of the function of time and circadian timing in Circadian the complex neurobiology around ketamine. Indeed, the acute pharmacological effects of a single ketamine treat- Plasticity ment last for only a few hours, whereas the antidepressant effects peak at around 24 hours and are sustained for Depression the following few days. Numerous studies have investigated the acute and long-lasting neurobiological changes Rapid-acting antidepressant Slow-wave sleep induced by ketamine; however, the most dramatic and fundamental change that the brain undergoes each day is rarely taken into consideration. Here, we explore the link between sleep and circadian regulation and rapid-act- ing antidepressant effects and summarize how diverse phenomena associated with ketamine’s antidepressant actions – such as cortical excitation, synaptogenesis, and involved molecular determinants – are intimately con- nected with the neurobiology of wake, sleep, and circadian rhythms.
    [Show full text]
  • Bright Light Therapy for Bipolar Depression
    Bright light therapy for bipolar depression Evidence suggests efficacy as an adjunctive treatment right light therapy (BLT) refers to the use of bright light to treat symptoms of depression. BLT was initially pre- scribed as a treatment for patients with seasonal affec- B 1 tive disorder. It was later found helpful for nonseasonal depression,2 premenstrual dysphoric disorder, postpartum depression, and phase shift circadian disorders, including for patients with dementia whose cognitive function improved after treatment with BLT.3 More recent studies suggest year- round benefit for nonseasonal depression.2 The American Psychiatric Association practice guidelines for the treatment of depression list BLT as an alternative and/or addition to pharmacologic and psychological treatment.4 BLT also may be beneficial for patients who are in the depressive phase of bipolar illness. This article describes the evidence, rationale for use, ANDRZEJ WOJCICKI mechanism of action, benefits, and safety profile of BLT for Suhayl J. Nasr, MD Ahmed Z. Elmaadawi, MD treating patients with bipolar depression. Professor of Psychiatry Adjunct Assistant Professor Indiana University School of Psychiatry of Medicine Indiana University School Indianapolis, Indiana of Medicine Circadian rhythm disruption in bipolar disorder Chief of Behavioral Indianapolis, Indiana Clinical manifestation. Patients with bipolar disorder (BD) Health Services Director of Interventional spend more time in depression than in mania.5 Sleep distur- Beacon Health System Psychiatry Division South Bend, Indiana Beacon Health System bance is a core symptom of BD; patients typically have little South Bend, Indiana need for sleep during a manic episode, and excess sleepiness Rikinkumar Patel, MD, during a depressive episode.
    [Show full text]
  • Photobiomodulation and the Brain: a New Paradigm
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author J Opt. Author Manuscript Author manuscript; Manuscript Author available in PMC 2018 January 01. Published in final edited form as: J Opt. 2017 January ; 19(1): 013003–. doi:10.1088/2040-8986/19/1/013003. Photobiomodulation and the brain: a new paradigm Madison Hennessy1 and Michael R Hamblin2,3,4 1Briarcliff High School, Briarcliff Manor, NY, USA 2Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA 3Department of Dermatology, Harvard Medical School, Boston, MA, USA 4Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA Abstract Transcranial photobiomodulation (PBM) also known as low level laser therapy (tLLLT) relies on the use of red/NIR light to stimulate, preserve and regenerate cells and tissues. The mechanism of action involves photon absorption in the mitochondria (cytochrome c oxidase), and ion channels in cells leading to activation of signaling pathways, up-regulation of transcription factors, and increased expression of protective genes. We have studied PBM for treating traumatic brain injury (TBI) in mice using a NIR laser spot delivered to the head. Mice had improved memory and learning, increased neuroprogenitor cells in the dentate gyrus and subventricular zone, increased BDNF and more synaptogenesis in the cortex. These highly beneficial effects on the brain suggest that the applications of tLLLT are much broader than at first conceived. Other groups have studied stroke (animal models and clinical trials), Alzheimer’s disease, Parkinson’s disease, depression, and cognitive enhancement in healthy subjects. Keywords Transcranial photobiomodulation; low level laser therapy; brain disorders; traumatic brain injury; stroke; Alzheimer’s disease; psychiatric diseases 1 Introduction Light in the visible and near-infrared spectrum makes up the major part of solar radiation and is also provided by artificial light sources.
    [Show full text]
  • Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With
    Diabetes Care Volume 42, April 2019 529 Annelies Brouwer,1 Daniel H. van Raalte,2 Effects of Light Therapy on Mood Hoang-Ton Nguyen,3 Femke Rutters,4 CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL Peter M. van de Ven,4 Petra J.M. Elders,5 and Insulin Sensitivity in Patients Annette C. Moll,3 Eus J.W. Van Someren,1,6,7 Frank J. Snoek,8 With Type 2 Diabetes and Aartjan T.F. Beekman,1 and Depression: Results From a Marijke A. Bremmer1 Randomized Placebo-Controlled Trial Diabetes Care 2019;42:529–538 | https://doi.org/10.2337/dc18-1732 1Amsterdam UMC, Vrije Universiteit, and GGZ inGeest, Department of Psychiatry, Amsterdam Public Health research institute, Amsterdam, the OBJECTIVE Netherlands 2Amsterdam UMC, Vrije Universiteit, Depart- Depression is common in patients with type 2 diabetes and adversely affects ment of Internal Medicine, Diabetes Center, quality of life and diabetes outcomes. We assessed whether light therapy, an Amsterdam, the Netherlands 3 antidepressant, improves mood and insulin sensitivity in patients with depression and Amsterdam UMC, Vrije Universiteit, Depart- ment of Ophthalmology, Amsterdam, the Nether- type 2 diabetes. lands 4Amsterdam UMC, Vrije Universiteit, Depart- RESEARCH DESIGN AND METHODS ment of Epidemiology and Biostatistics, Am- This randomized, double-blind, placebo-controlled trial included 83 patients with sterdam Public Health research institute, depression and type 2 diabetes. The intervention comprised 4 weeks of light Amsterdam, the Netherlands 5Amsterdam UMC, Vrije Universiteit, Depart- therapy (10,000 lux) or placebo light therapy daily at home. Primary outcomes ment of General Practice and Elderly Care included depressive symptoms (Inventory of Depressive Symptomatology [IDS]) Medicine, Amsterdam Public Health research and insulin sensitivity (M-value derived from the results of a hyperinsulinemic- institute, Amsterdam, the Netherlands 6 euglycemic clamp).
    [Show full text]
  • Depression in Adults: Treatment and Management
    Depression in adults: treatment and management Appendix J11: study characteristics for evidence from previous versions of the guideline (St John’s wort, seasonal affective disorder and relapse prevention) Depression in adults: Appendix J11 1 Contents Treatment of a new depressive episode ................................................................................................. 3 St John’s wort - studies in 2004 guideline ........................................................................................... 3 Seasonal affective disorder ................................................................................................................. 8 Light therapy - new studies in the guideline update ...................................................................... 8 Non-light therapy interventions for depression with a seasonal pattern/SAD ............................ 31 Relapse prevention ............................................................................................................................... 35 2004 Guideline .............................................................................................................................. 35 2009 Guideline .............................................................................................................................. 40 Seasonal affective disorder ............................................................................................................... 49 Non-light therapy interventions for depression with a seasonal pattern/SAD -
    [Show full text]
  • The Use of Bright Light in the Treatment of Insomnia
    Chapter e39 The Use of Bright Light in the Treatment of Insomnia Leon Lack and Helen Wright Department of Psychology, Flinders University, Adelaide, South Australia PROTOCOL NAME The use of bright light in the treatment of insomnia. GROSS INDICATION Certain types of insomnia that are associated with abnormal timing of circa- dian rhythms may be treated with bright light therapy. SPECIFIC INDICATION Some individuals with sleep onset insomnia experience difficulty falling asleep at a “normal time” but no difficulty maintaining sleep once it is initi- ated. Individuals with this type of insomnia may have a delayed or later timed circadian rhythm. Bright light therapy timed in the morning after arising can advance or time circadian rhythms earlier and thus would be indicated for sleep onset or initial insomnia. Morning bright light therapy is also indicated for the related problem of delayed sleep phase disorder. Individuals experiencing early morning awakening insomnia have no diffi- culty initiating sleep but their predominant difficulty is waking before intended and not being able to resume sleep. These individuals may have an advanced or early timed circadian rhythm. Bright light therapy in the evening before sleep would be indicated for this type of insomnia as well as for the more extreme version, advanced sleep phase disorder. CONTRAINDICATIONS Bright light therapy would not be recommended in the following cases: ● Insomnia in which there is no indication of abnormal timing of circadian rhythms (e.g. combined problem initiating and maintaining sleep, having no strong morning or evening activity preferences) Behavioral Treatments for Sleep Disorders. DOI: 10.1016/B978-0-12-381522-4.00053-5 © 2011 Elsevier Inc.
    [Show full text]
  • Circadian Rhythms and Depression Sleep-Wake Cycle Is out of Phase with the Day- in the Day, While Bright Light Applied in the with Remission in Spring and Summer)
    CLINICAL Circadian rhythms Philip Boyce Erin Barriball and depression However, current treatments have been developed Background on the basis of a causal model for depression. Depression is a common disorder in primary care. Disruptions to the circadian rhythms Focused psychological treatments target those associated with depression have received little attention yet offer new and exciting depressions that arise from psychosocial approaches to treatment. difficulties. Examples include: Objective • cognitive behavioural therapy (CBT), which This article discusses circadian rhythms and the disruption to them associated with corrects maladaptive thinking patterns depression, and reviews nonpharmaceutical and pharmaceutical interventions to shift • behavioural treatments that aim to overcome circadian rhythms. ‘depressogenic’ behaviours such as avoiding Discussion pleasurable activities, and Features of depression suggestive of a disturbance to circadian rhythms include early • lifestyle modifications, particularly work-life morning waking, diurnal mood changes, changes in sleep architecture, changes in balance, diet and exercise and sleep-wake timing of the temperature nadir, and peak cortisol levels. Interpersonal social rhythm cycle management.5 therapy involves learning to manage interpersonal relationships more effectively Antidepressant medications target the and stabilisation of social cues, such as including sleep and wake times, meal times, neurotransmitter disturbances (serotonin or and timing of social contact. Bright light therapy is used to treat seasonal affective noradrenaline) considered to underlie biological disorders. Agomelatine is an antidepressant that works in a novel way by targeting depression. While the focus of biological melatonergic receptors. aspects of depression has centred on changes in Keywords: circadian rhythm, depression neurotransmitters, there has been relatively little attention paid to the changes in circadian rhythms associated with depression that offer new and rational treatment options for depression.
    [Show full text]
  • Sleep Deprivation Increases Dorsal Nexus Connectivity to the Dorsolateral Prefrontal Cortex in Humans
    Sleep deprivation increases dorsal nexus connectivity to the dorsolateral prefrontal cortex in humans Oliver G. Boscha,1, Julia S. Rihmb, Milan Scheideggera,c, Hans-Peter Landoltd, Philipp Stämpflie, Janis Brakowskia, Fabrizio Espositof, Björn Raschg, and Erich Seifritza aDepartment of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, 8032 Zurich, Switzerland; bDivision of Biopsychology, Department of Psychology, University of Zurich, 8050 Zurich, Switzerland; cInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, 8092 Zurich, Switzerland; dInstitute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland; eMR-Center of the Hospital of Psychiatry and the Department of Child and Adolescent Psychiatry, University of Zurich, 8032 Zurich, Switzerland; fDepartment of Medicine and Surgery, University of Salerno, 84081 Baronissi, Italy; and gDivision of Cognitive Biopsychology and Methods, Department of Psychology, University of Fribourg, 1701 Fribourg, Switzerland Edited by Marcus E. Raichle, Washington University in St. Louis, St. Louis, MO, and approved October 21, 2013 (received for review September 18, 2013) In many patients with major depressive disorder, sleep depriva- areas such as hypothalamus, amygdala, entorhinal cortex, and tion, or wake therapy, induces an immediate but often transient nucleus accumbens (18, 19). antidepressant response. It is known from brain imaging studies Increased connectivity of DMN, CCN, and AN with a distinct that changes
    [Show full text]
  • Light Therapy and Seasonal Affective Disorder (SAD)
    Standard Research Article Psychother Psychosom 2020;89:17–24 Received: May 23, 2019 DOI: 10.1159/000502891 Accepted after revision: August 22, 2019 Published online: October 1, 2019 The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials a a a, b a c Edda Pjrek Michaela-Elena Friedrich Luca Cambioli Markus Dold Fiona Jäger a a a a Arkadiusz Komorowski Rupert Lanzenberger Siegfried Kasper Dietmar Winkler a Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; b Competence Center for Eating Behavior, Obesity and the Psyche, Zofingen Hospital, Zofingen, Switzerland; c University Medical Center Freiburg, University of Freiburg, Freiburg, Germany Keywords moderate heterogeneity of the studies and a moderate-to- Seasonal affective disorder · Winter depression · high risk of bias. Conclusions: BLT can be regarded as an ef- Bright light therapy · Meta-analysis fective treatment for SAD, but the available evidence stems from methodologically heterogeneous studies with small- to-medium sample sizes, necessitating larger high-quality Abstract clinical trials. © 2019 S. Karger AG, Basel Background: Bright light therapy (BLT) has been used as a treatment for seasonal affective disorder (SAD) for over 30 years. This meta-analysis was aimed to assess the efficacy of BLT in the treatment of SAD in adults. Method: We per- Introduction formed a systematic literature search including randomized, single- or double-blind clinical trials investigating BLT Seasonal affective disorder (SAD) is a subtype of recur- ( 1,000 lx, light box or light visor) against dim light ( 400 lx) ≥ ≤ rent major depressive or bipolar disorder defined by a or sham/low-density negative ion generators as placebo.
    [Show full text]